From: HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?
 | OR | IC 95% | P value | P value |
---|---|---|---|---|
Age (n = 292) | ||||
 < 50 | Reference | 0.430–1.088 | 0.109 |  |
 ≥ 50 | 0.684 | |||
Histologic type (n = 291) | ||||
Lobular or other | Reference | 1.111–69.6 | 0.039 | 0.033 |
No special type | 8.792 | |||
Grade of invasive component (n = 284) | ||||
1 | Reference | Â | Â | Â |
2 | 1.439 | 0.251–8.231 | 0.683 |  |
3 | 1.789 | 0.320–10.01 | 0.508 |  |
Angioinvasion (n = 230) | ||||
No or uncertain | Reference | 0.241–1.677 | 0.36 |  |
Yes | 0.635 | |||
Mitosis (n = 95) | ||||
≥ 8 | Reference | 0.358–2.263 | 0.823 |  |
< 8 | 0.9 | |||
Ki67 (n = 27) | ||||
< 40 | Reference | 0.056–8.822 | 0.783 |  |
≥ 40 | 0.7 | |||
sTILs percentage (n = 292) | ||||
< 10 | Reference | 1.086–2.899 | 0.022 | 0.011 |
≥ 10 | 1.77 | |||
Axillary nodal status (n = 260) | ||||
Positive | Reference | 0.483–1.308 | 0.366 |  |
Negative | 0.794 | |||
HER2 status (n = 292) | ||||
HER2 0 | Reference | 0.498–1.271 | 0.339 |  |
HER2 low | 0.797 |